The outbreak of the Covid-19 pandemic has produced its strongest effects on NHS companies, which have dealt with an incredible increase in costs. Consequently, the urgency of a separated reporting of Covid-related expenses has led to specific legislative actions which have imposed strict requirements for the presentation of interim financial statements entirely dedicated to the effect of the pandemic.

Special credits to Prof. Ebron D’Aristotile, co-author of the publication.